Business
Comprehensive Healthcare Systems Announces Closing of First Tranche of Private Placement
Calgary, Alberta--(Newsfile Corp. - February 12, 2026) - Comprehensive Healthcare Systems Inc. (TSXV: CHS) (the "Company" or "CHS"), an industry leader in healthcare benefits administration software and services, is pleased to announce that it has closed the first tranche of its non-brokered private placement (the "Offering") announced on January 8, 2026 and January 26, 2026, issuing an aggregate of 7,000,000 units ("Units") at $0.50 per Unit for aggregate gross proceeds of $3,500,000. Each Unit
About this update from Comprehensive Healthcare Systems Inc
[{"type":"text","content":"Calgary, Alberta--(Newsfile Corp. - February 12, 2026) - Comprehensive Healthcare Systems Inc. (TSXV: CHS) (the "Company" or "CHS"), an industry leader in healthcare benefits administration software and services, is pleased to announce that it has closed the first tranche of its non-brokered private placement (the "Offering") announced on January 8, 2026 and January 26, 2026, issuing an aggregate of 7,000,000 units ("Units") at $0.50 per Unit for aggregate gross proceeds of $3,500,000.","length":530,"tagName":"p"},{"type":"text","content":"Each Unit was comprised of one common share of the Company ("Shares") and one-half of a warrant, with a whole warrant ("Warrants") being exercisable to purchase one common share of the Company at an exercise price of $1.00 for a period of three years after closing.","length":285,"tagName":"p"},{"type":"text","content":""PowerOne Capital Markets Limited" acted as finder in connection with a portion of the offering. In connection with the first tranche, the Company paid aggregate finder fees of $214,200 in cash and issued an aggregate of 428,400 finder warrants exercisable to purchase one common share of the Company at an exercise price of $0.50 for a period of three years after closing. All securities issued are subject to a hold period until June 11, 2026.","length":455,"tagName":"p"},{"type":"text","content":"An insider of the Company purchased 945,000 Units, representing 13.5% of the Units issued in the first tranche, with the associated common shares representing approximately 3.8% of the issued and outstanding shares upon closing, and assuming the deemed exercise of the associated warrants would then represent approximately 5.6% of the then issued and outstanding shares upon closing. The participation by insiders constitutes a "related party transaction" under the policies of the TSXV and Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company is relying upon the exemptions from the formal valuation and minority shareholder approval requirements contained in sections 5.5(a) and (b), and 5.7(1)(a), respectively, of MI 61-101 on the basis that neither the fair market value of the subject matter of nor of the consideration for the transa...